Shares of Intel Corporation (NASDAQ: INTC) fell sharply during Friday’s session. Intel reported upbeat results for its fourth quarter, but issued a weak forecast for the first quarter.
Panbela Therapeutics, Inc. announces the publication of clinical data from studies of CPP-1X or Eflornithine) in neuroblastoma. According to Hogarty et al, children with relapsed refractory.
Panbela (PBLA) announces publication of clinical data from studies of CPP-1X in neuroblastoma streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MINNEAPOLIS, Jan. 18, 2024 (GLOBE NEWSWIRE) Panbela Therapeutics, Inc. (Nasdaq: PBLA), a clinical stage biopharmaceutical company developing disruptive therapeutics for the treatment of patients with urgent unmet medical needs